Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Fukuyama M, Ito T, Ohyama M. Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines. J Dermatol. 2022;49(1):19–36.
2. Tsuboi R, Itami S, Manabe S, et al. Japanese Dermatological Association Alopecia areata clinical practice guidelines. Jpn J Dermatol. 2017;127(13):2741–62 (in Japanese).
3. King BA, Senna MM, Ohyama M, et al. Defining severity in alopecia areata: current perspectives and a multidimensional framework. Dermatol Ther (Heidelb). 2022;12(4):825–34.
4. Tan E, Tay YK, Goh CL, Chin GY. The pattern and profile of alopecia areata in Singapore—a study of 219 Asians. Int J Dermatol. 2002;41(11):748–53.
5. Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990–2009. J Invest Dermatol. 2014;134(4):1141–2.